Take a free trial today. Take a free trial of Briefing In Play. Take a free trial of Briefing In Play Plus. Take a free trial of Briefing Trader. Learn about our premium services. Take a tour of our premium services. Can't Decide? Compare all services here. We are here to help, email customer service. We are here to help, call customer service. Take a free trial today. Take a free trial of Briefing In Play. Take a free trial of Briefing In Play Plus. Take a free trial of Briefing Trader. Learn about our premium services. Take a tour of our premium services. Can't Decide? Compare all services here. We are here to help, email customer service. We are here to help, call customer service.
[BRIEFING.COM] U.S. stocks have continued to surrender their earlier gains and are now relatively flat for the day. Despite the broad market sell-off, sector-wide strength in Biotechnology remains following this morning's ABBV/PCYC acquisition news. Some notable...
Initial public offerings scheduled to price in the current week.
Ticker Underwriter
No IPOs priced this week.
Wednesday was another day of profit taking that knocked each of the indices back a bit from their lofty levels. There was nothing panicky about the selling, which followed a somewhat technical script. To that end, the early selling interest subsided when the S&P 500...
 
Close
You are a paid subscriber. Please select the service you would like to access:
ProductPick